newsfilter
← Latest News
Business Wire·

ImmunoCellular Therapeutics Reports Third Quarter 2012 Financial Results

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced third quarter results for the period ended September 30, 2012.